Latest AbbVie Inc. Stories
NORTH CHICAGO, Ill., April 17, 2015 /PRNewswire/ -- AbbVie Inc.
NEW YORK, March 12, 2015 /PRNewswire/ -- AbbVie's recent acquisition of Pharmacyclics for $21 billion strengthens AbbVie's already comprehensive pipeline and increases the company's growth prospects,
- Adds Imbruvica® a first in class BTK inhibitor approved in multiple indications for blood cancers. NORTH CHICAGO, Ill.
NORTH CHICAGO, Ill., Feb. 19, 2015 /PRNewswire/ -- The board of directors of AbbVie Inc.
DUBLIN, Ireland, February 12, 2015 /PRNewswire/ -- Shire (LSE: SHP, NASDAQ: SHPG) announces unaudited results for the year to December 31, 2014.
- Reports Full-Year Adjusted EPS of $3.32, Up 5.7 Percent; GAAP EPS $1.10 NORTH CHICAGO, Ill., Jan.
ReportsnReports.com adds Hepatitis C Global Clinical Trials Review H2 2014 to its store.
NBI-98854 Phase III Program Underway for Tardive Dyskinesia SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc.
- Reports Third-Quarter Adjusted EPS of $0.89, Up 8.5 Percent and Well Above the Previous Guidance Range of $0.77 to $0.79; Reports GAAP EPS of $0.31 NORTH CHICAGO, Ill., Oct.
- Will announce third-quarter 2014 financial results on Oct. 31, 2014 - NORTH CHICAGO, Ill., Oct. 20, 2014 /PRNewswire/ -- The board of directors of AbbVie Inc.
- Growing in low tufty patches.